Ebina, Teresita P.

HRN: 21-84-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/01/2023
09/08/2023
IV
500mg
Q8
Intra-abdominal Infection
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: